{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:09:43Z","timestamp":1780434583320,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.metabol.2009.09.006","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T04:22:04Z","timestamp":1258345324000},"page":"628-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population"],"prefix":"10.1016","volume":"59","author":[{"given":"Altan","family":"Onat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclay","family":"Hergen\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnay","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekeriya","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcsniye","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2009.09.006_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","article-title":"Critical review of acylation-stimulating protein physiology in humans and rodents","volume":"1609","author":"Cianflone","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2009.09.006_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0145-305X(01)00034-9","article-title":"Phylogenetic aspects of the complement system","volume":"25","author":"Zarkadis","year":"2001","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.metabol.2009.09.006_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1053\/euhj.1999.2013","article-title":"Relationship of serum C3 to fasting insulin, risk factors and previous ischemic events in middle aged men","volume":"21","author":"Muscari","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2009.09.006_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/CS20040198","article-title":"Cross-sectional study of complement C3 as a coronary risk factor among men and women","volume":"108","author":"Onat","year":"2005","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2009.09.006_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0026-0495(93)90215-A","article-title":"Coordinate regulation of triacyglycerol synthesis and glucose transport by acylation-stimulating protein","volume":"42","author":"Germinario","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2009.09.006_bib6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI116733","article-title":"The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis","volume":"92","author":"Baldo","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2009.09.006_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0002-9343(99)80314-3","article-title":"Association of serum C3 levels with the risk of myocardial infarction","volume":"98","author":"Muscari","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2009.09.006_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.hjr.0000244582.30421.b2","article-title":"Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study","volume":"14","author":"Engstr\u00f6m","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.metabol.2009.09.006_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.11.034","article-title":"Serum complement C3\/C4 ratio, a novel marker for recurrent cardiovascular events","volume":"99","author":"Palikhe","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2009.09.006_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00041433-200310000-00008","article-title":"Role of complement activation in atherosclerosis","volume":"14","author":"Oksjoki","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2009.09.006_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2006.01.009","article-title":"The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers","volume":"190","author":"van Oostrom","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2009.09.006_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-4-28","article-title":"Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?","volume":"4","author":"Kraja","year":"2007","journal-title":"Nutr Metab"},{"key":"10.1016\/j.metabol.2009.09.006_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"National Cholesterol Education Expert Panel","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2009.09.006_bib14","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.2337\/dc07-0637","article-title":"Pianoro Study Group. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population","volume":"30","author":"Muscari","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2009.09.006_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diabetes.54.2.570","article-title":"Complement C3 is a risk factor for the development of diabetes: a population-based cohort study","volume":"54","author":"Engstr\u00f6m","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.09.006_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(02)00236-8","article-title":"Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels\u2014a prospective and cross-sectional evaluation","volume":"165","author":"Onat","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2009.09.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00500-7","article-title":"Risk factors and cardiovascular disease in Turkey","volume":"156","author":"Onat","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2009.09.006_bib18","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2009.09.006_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.09.006_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2006.03.012","article-title":"Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study","volume":"191","author":"Onat","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2009.09.006_bib21","series-title":"Cardiovascular survey methods","first-page":"124","author":"Rose","year":"1982"},{"key":"10.1016\/j.metabol.2009.09.006_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.ijo.0803173","article-title":"Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes","volume":"30","author":"Yang","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2009.09.006_bib23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.metabol.2009.05.004","article-title":"Impaired protection against diabetes and coronary disease by high-density lipoproteins in Turks","volume":"30","author":"Onat","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2009.09.006_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-5491.2009.02814.x","article-title":"Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor among Turks","volume":"26","author":"Onat","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2009.09.006_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2006.07.002","article-title":"Prospective epidemiologic evidence of a \u201cprotective\u201d effect of smoking on metabolic syndrome and diabetes among Turkish women\u2014without associated overall health benefit","volume":"193","author":"Onat","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2009.09.006_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1538-7836.2007.02434.x","article-title":"Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with metabolic syndrome","volume":"5","author":"Ajjan","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2009.09.006_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1530\/EJE-08-0467","article-title":"Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents","volume":"159","author":"Wamba","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2009.09.006_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2007.09.002","article-title":"Serum C-reactive protein as an independent risk factor predicting cardiometabolic risk","volume":"57","author":"Onat","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2009.09.006_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1160\/TH05-06-0384","article-title":"Complement C3 and C-reactive protein levels in patients with stable coronary artery disease","volume":"94","author":"Ajjan","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.metabol.2009.09.006_bib30","article-title":"The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks","author":"Onat","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:47:11Z","timestamp":1758426431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049509003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0026049509003801"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2009.09.006","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2009.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}